Lecture 2- memory and vaccination Flashcards

1
Q

what are the objectives?

A
  • The cellular basis of immunological memory and how this allows
    vaccine induced immunity
  • Current status of vaccination in the UK (see 2X Fundamental topics
    in Biology)
  • New/experimental approaches to vaccine design - Live Recombinant
    vaccines
  • What vaccine adjuvants are and their functions in vaccine
    formulations
  • New/experimental approaches to vaccine design - Nucleic Acid
    vaccines
  • The current status of research into SARS-CoV-2 vaccines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the protein / adjuvant vaccines?

A
  • Sanofi/GSK vs Novavax vaccine trials
  • Novavax - Spike protein formulated in Matrix M adjuvant
  • Sanofi/GSK - Spike protein formulated in AS04 - Alum and
    MPLA (TLR4 agonist)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the clinical uses of adjuvants?

A
  • adjuvant activity of Aluminium precipitates first described in
    1926
  • was the only adjuvant approved for human vaccines in UK until
    2007
  • a component of:
    – Diphtheria, Tetanus, Pertussis, Inactivated Polio, Meningitis C,
    B, ACWY, Pneumococcus, Hemophilus Influenzae, Hepatitis A,
    Hepatitis B vaccines, Gardasil.
  • Induces Th2 responses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

why study adjuvants?

A
  • Non-living vaccines do not
    stimulate strong immune
    responses —> Adjuvants can
    provide this stimulus
  • Adjuvants have a broad range of
    positive effects on vaccine
    performance
  • Adjuvants are a critical factor in
    vaccine development
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are adjuvants?

A

“Agents which act non-specifically to
increase the specific immune response
or responses to an antigen”
The Dictionary of Immunology
“the immunolgists dirty little secret”
Charles Janeway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are features of memory T cells?

A
  • Increased frequency.
  • Lower activation thresholds
  • Better effector function
  • Changes in expression of adhesion molecules, eg. CD44,
    ICAM-1, LFA-1,LFA-3 & α4-integrin, as well as chemokine
    receptors.
  • Altered migration pathways (Tcm/Tem)
    T Memory cells have faster/ better effector function
    Different migratory capacities of T memory cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are conjugate vaccines?

A
  • High titres/high affinity/class switched Ab
    against carbohydrates protect against e.g.
    Haemophilus Influenzae and
    Meningicoccal infections
  • BUT! Carbohydrates can’t induce high
    titre/affinity/class switched Ab responses.
  • Because T cells can’t respond to
    carbohydrates (they only recognise
    peptides in the context of MHC) —>
    You don’t get T cell help for B cell Ab
    production (no germinal centre
    reaction)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the features of memory b cells?

A
  • Increased frequency
  • Express switched isotypes (IgG, IgA, IgE).
    –Better effector function (e.g. complement activation,
    opsonisation)
  • Express somatically mutated Ig V genes.
  • Express higher affinity Ig.
  • Lower activation thresholds/Faster formation of Plasma Cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

why are secondary Ab responses better?

A
  • The Germinal Centre reaction drives affinity maturation and
    class switching of Memory B cells and Long Lived Plasma Class
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how to conjugate a carbohydrate to a protein?

A
  1. B cell receptors recognise Hapten
  2. Conjugate is internalised and carrier
    degraded into peptides
  3. Peptides are presented to T cells in context of MHC II.
  4. Peptide (carrier) specific T cells recognise peptide/MHCII
  5. Carrier specific T cells provide
    B cell help
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are attenuated recombinant vaccines?

A
  • Insert protective antigen genes into attenuated pathogen to act as
    a carrier
  • Mostly Viruses (eg. Vaccinia, Adenovirus)
  • Live Attenuated Influenza Vaccine (LAIV) - (see 2X Fundamental
    topics in Biology)
  • Replication defective e.g.
    – Modified Vaccinia Ankara (Malaria, TB & HIV)
    – Adenovirus - ChAdOx, Ad5, Ad26 (SARS-CoV-2)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the 10 threats to global health in 2019?

A
  • Air pollution and climate
  • NCD
  • Flu pandemic
  • Fragile and vunerable settings
    (e.g. weakened health
    services)
  • AMR
  • Ebola and other high threat
    pathogens
  • Weak primary care
  • Dengue
  • HIV
  • Vaccine hesitancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what vaccines require thI immunity?

A
  • Bacterial
    – Tuberculosis
    – Leprosy
  • Viral
    – HIV
    – Influenza
  • Parasite
    – Malaria
    – Leishmaniasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what do nucleic acids vaccines have?

A

a built in adjuvant
* TLR3, TLR7, TLR8 and TLR9
* All recognise Nucleic Acids
* To sense viral infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly